(0.50%) 5 071.75 points
(0.38%) 38 215 points
(0.63%) 17 548 points
(0.58%) $79.46
(0.98%) $1.951
(0.54%) $2 323.50
(0.06%) $26.77
(1.41%) $968.40
(0.03%) $0.933
(-0.02%) $11.03
(-0.08%) $0.798
(-0.46%) $92.83
Live Chart Being Loaded With Signals
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center...
Stats | |
---|---|
本日の出来高 | 13 917.00 |
平均出来高 | 5 644.00 |
時価総額 | 68.84M |
EPS | CHF0 ( 2024-04-16 ) |
次の収益日 | ( CHF0 ) 2024-05-13 |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E | -8.57 |
ATR14 | CHF0 (0.00%) |
SHL Telemedicine Ltd 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
SHL Telemedicine Ltd 財務諸表
Annual | 2023 |
収益: | CHF57.08M |
総利益: | CHF25.26M (44.26 %) |
EPS: | CHF-0.430 |
FY | 2023 |
収益: | CHF57.08M |
総利益: | CHF25.26M (44.26 %) |
EPS: | CHF-0.430 |
FY | 2022 |
収益: | CHF59.00M |
総利益: | CHF27.19M (46.08 %) |
EPS: | CHF-0.00490 |
FY | 2021 |
収益: | CHF49.58M |
総利益: | CHF24.59M (49.60 %) |
EPS: | CHF-0.135 |
Financial Reports:
No articles found.
SHL Telemedicine Ltd
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。